Cleared Traditional

K192001 - Sterilucent self-Contained Biological I...

K192001 is the FDA 510(k) clearance for Sterilucent self-Contained Biological I... by Sterilucent, Inc.. It is a Class 2 General Hospital device (product code FRC) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
88d
Days
Class 2
Risk

K192001 is an FDA 510(k) clearance for the Sterilucent self-Contained Biological Indicator, Sterilucent Lumen Cycle Proc.... Classified as Indicator, Biological Sterilization Process (product code FRC), Class II - Special Controls.

Submitted by Sterilucent, Inc. (Minneapolis, US). The FDA issued a Cleared decision on October 22, 2019 after a review of 88 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.2800 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sterilucent, Inc. devices

Submission Details

510(k) Number K192001 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2019
Decision Date October 22, 2019
Days to Decision 88 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 129d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRC Indicator, Biological Sterilization Process
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRC Indicator, Biological Sterilization Process

All 114
Devices cleared under the same product code (FRC) and FDA review panel - the closest regulatory comparables to K192001.
3MTM AttestTM Mini Auto-reader 490M
K200092 · 3M · Apr 2020
3M Attest Super Rapid 5 Steam-Plus Challenge Pack
K193154 · 3M Company · Feb 2020
STERRAD VELOCITY Biological Indicator/Process Challenge Device and Reader
K192025 · Advanced Sterilization Products (Asp) · Jan 2020
Terragene Bionova, Terragene Bionova, Terragene Integron, Terragene Cintape, Terragene Chemdye
K191021 · Terragene S.A. · Sep 2019
Celerity HP Incubator
K190297 · STERIS Corporation · May 2019
CELERITY 20 HP Biological Indicator, CELERITY HP Challenge Pack
K183294 · STERIS Corporation · Jan 2019